DNA vaccines encoding CEA and a CD40 ligand and methods of...

Details DNA vaccines encoding CEA and a CD40 ligand and methods of... DNA vaccines encoding CEA and a CD40 ligand and methods of...

2007-10-09

2007-10-09

Campell, Bruce R. (Department: 1648)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Carbohydrate doai

C435S320100, C435S070100, C424S192100

Reexamination Certificate

active

11195506

ABSTRACT:
A DNA vaccine effective for eliciting an immune response against cells that present a carcinoembryonic antigen (CEA) comprises a DNA operably encoding a CEA and a DNA operably encoding a CD40 ligand, SEQ ID NO:1 and SEQ ID NO: 2, respectively, or its homotrimer, CD40LT. The DNA vaccine can be incorporated in a delivery vector such as an attenuated live bacterium or virus, or a liposome carrier. In a method embodiment, the DNA vaccine is administered orally to a mammal, such as a human, to elicit an immune response against CEA presenting cells such as colon cancer cells. A preferred method embodiment includes the additional step of treating the mammal with recombinant antibody fusion protein huKS1/4-IL2 to enhance the immune response effectiveness of the vaccine.

REFERENCES:
Xiang et al. J. Immunol. 2001, vol. 167, pp. 4560-4565.

Affiliated with

Also associated with

Rating

DNA vaccines encoding CEA and a CD40 ligand and methods of... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with DNA vaccines encoding CEA and a CD40 ligand and methods of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and DNA vaccines encoding CEA and a CD40 ligand and methods of... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3897840